| 发明名称 |
Treatment for rheumatoid arthritis |
| 摘要 |
<p>The present invention provides anti-GM-CSF antibodies for use in the treatment of rheumatoid arthritis. Anti-GM-CSF antibodies, in particular MOR103, are administered to patients suffering from rheumatoid arthritis at dosages that are beneficial in a clinical setting.</p> |
| 申请公布号 |
AU2013320261(A1) |
申请公布日期 |
2015.04.09 |
| 申请号 |
AU20130320261 |
申请日期 |
2013.09.19 |
| 申请人 |
MORPHOSYS AG |
发明人 |
HAERTLE, STEFAN;LECLAIR, STEPHANE;SHEBL, AMGAD;STEIDL, STEFAN |
| 分类号 |
C07K16/24;A61K39/395;A61P29/00 |
主分类号 |
C07K16/24 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
